Providence Secures FDA Clearance for 3D-Printed Titanium Cervical Fusion Implant

Providence Medical Technology has received FDA 510(k) clearance for its CORUS™ Posterior Cervical Stabilization System 3D-T (CORUS™ PCSS 3D-T), a next-generation implant designed to support posterior cervical fusion in patients with degenerative disc disease. 

The device combines the existing CORUS PCSS design with a 3D-printed porous titanium structure engineered to support bone growth and spinal stabilisation.

Its interconnected titanium lattice is designed to resemble cancellous bone, providing pathways for vascularisation and bone ingrowth. The structure has approximately 1.5 times more surface area and eight times greater surface roughness than the previous machined implant.

The implant also features integrated screw fixation and openings that allow bone graft material to be packed within the device. Its design supports load distribution and accommodates variations in patient anatomy.

CORUS PCSS 3D-T is placed through a posterior surgical approach and is intended to stabilise up to three consecutive cervical spinal levels, from C3 to C7. It is used as an adjunct to posterior cervical fusion alongside appropriate anterior spinal stabilisation hardware.

Clinical evidence from a randomised trial of the previous-generation CORUS PCSS demonstrated higher fusion rates at 12 and 24 months and fewer surgical revisions when combined with multilevel anterior fusion compared with anterior fusion alone. These findings relate to the earlier design, rather than the newly introduced 3D-T implant.